UNSPSC 51422506: Cicortonide

This classification denotes a therapeutic glucocorticoid with the molecular formula C29H37ClFNO7, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier UL947A614K, chemically known as 3-(2-chloroethoxy)-9-fluoro-11beta, 16alpha,17,21-tetrahydroxy-20-oxopregna-3,5-diene-6-carbonitrile, cyclic 16,17-acetal with acetone, 21-acetate. but generally known as cicortonide, which bears US NIH Compound Identifier 193972.

UNSPSC 51422506 Cicortonide (Commodity) does not align with the recent state and local procurement activity posted under this code. The single recent opportunity on record is Seminole County, Florida's IFB 60459723LAS, posted June 30, 2026, which solicits naloxone and safe drug deactivation systems—neither of which relates to cicortonide, a topical corticosteroid pharmaceutical. The mismatch suggests the code has been misapplied to this procurement or that state and local agencies are using it inconsistently with its nominal scope.

The Seminole County opportunity calls for 1,900 units of naloxone and 800 safe drug deactivation systems annually with quarterly deliveries to the Seminole County Community Health Building in Sanford, Florida; the response deadline was July 26, 2023. Bidders must provide unit costs, comply with drug-free workplace certification and E-Verify requirements, maintain workers' compensation and liability insurance, and acknowledge potential FEMA funding with attendant federal compliance obligations. The contract runs two years with a one-year renewal option. No explicit set-aside designations were noted. The code shows little relevant recent activity in the state and local marketplace under its intended pharmaceutical scope.